Mediastinal tracheostomy: techniques, outcomes and quality of life—a systematic review Authors: Jonas Peter Ehrsam, Ana-Maria Petrone, Marko Aleksic, Paul Christian Fuchs, Steffen Maune, Theresa Stork, Stéphane Collaud Published: 2026 ABSTRACT BackgroundMediastinal tracheostomy (MT) is a rare, technically demanding salvage procedure in which the distal trachea is redirected into the upper mediastinum. It is indicated when extensive resection of the proximal trachea precludes conventional tracheal reconstruction or cervical tracheostomy. It is performed for a variety of underlying diseases. The aim of this systematic review was to summarize the available evidence on operative techniques, perioperative outcomes, disease-specific outcomes, and quality of life.MethodsA systematic review was conducted. PubMed was searched for case reports and case series. Data on surgical techniques, indications, perioperative outcomes, complications, and quality of life were descriptively analyzed.ResultsSeventy publications reporting 437 mediastinal tracheostomies over 85 years were identified. Of these, 429 were permanent anterior mediastinal tracheostomies, the predominant type. Several techniques have evolved for this procedure over time. Extended manubrial resection was performed in most cases, whereas hemi-manubrial resection (2.8%) has gained popularity in recent years. Although a tracheal stump length of ≥5 cm is generally recommended, 12.6% of tracheostomies were created with a stump measuring 0–4 cm. Tracheal transposition was performed in 52.9% of cases to increase tracheal length and avoid contact with the brachiocephalic artery. Initially, direct collar skin (20.3%) or bipedicled upper thoracic skin flaps (13.8%) were used for reconstruction; more recently, the pectoralis major myocutaneous flap (32.9%) has become the predominant technique. Postoperative mortality was 7.0% and decreased over time. Major complications included great vessel rupture (6.8%), tracheal necrosis (8.4%), and tracheal stenosis (9.6%). Patients with a tracheal stump length of 0–3cm had a failure rate of 33.3%. Available data did not permit reliable conclusions on outcomes for specific malignancy types. Quality-of-life data were scarce, although individual reports described independent daily living and return to strenuous work for more than 10 years.ConclusionsPermanent anterior MT remains the standard form of MT and can provide acceptable outcomes when meticulous surgical technique is applied. Tracheal transposition and well-vascularized muscle flap reconstruction appear to reduce procedure-related complications, particularly in patients with short tracheal remnants. Prospective multicenter studies are needed to define optimal surgical strategies, long-term oncological outcomes, and patient-reported quality of life. Highlight box Key findings • Among mediastinal tracheostomy (MT), permanent anterior MT is the predominant form. Surgical techniques have evolved considerably over time, resulting in lower postoperative morbidity and mortality. Limited hemi-manubrial resection, tracheal transposition in patients with short tracheal remnants, and coverage with a well-vascularized myocutaneous flap appear to improve surgical outcomes. Although evidence on quality of life is scarce, MT may allow patients to maintain independent daily living and even return to physically demanding work for more than 10 years. What is known and what is new? • MT is a rare and technically demanding salvage procedure that has historically been associated with high postoperative mortality and catastrophic vascular complications. • This is the first systematic review on MT. It includes 437 reported cases over an 85-year period and provides the largest and most comprehensive overview to date of surgical techniques, their evolution, postoperative outcomes, and reported quality-of-life outcomes. What is the implication, and what should change now? • Modern MT can achieve acceptable outcomes when meticulous surgical technique is applied. Tracheal transposition and vascularized flap reconstruction appear to reduce procedure-related complications, particularly in patients with short tracheal remnants. Future multicenter studies with standardized reporting are needed to define optimal surgical strategies, evaluate long-term oncological outcomes, and incorporate validated patient-reported quality-of-life measures. Introduction Mediastinal tracheostomy (MT) is a salvage procedure in which the distal trachea is redirected into the upper mediastinum. In most cases, this diversion is achieved through a window in the sternum in a procedure called anterior MT (AMT). An MT is required when a large portion of the proximal trachea must be resected and reconstruction of the trachea or a regular cervical tracheostomy is impossible due to insufficient remaining tracheal length. The procedure has curative and palliative intentions. Reasons for an extended proximal tracheal resection include: Primary malignancies of the upper trachea, malignancies of the subglottic larynx, thyroid, hypopharynx, or proximal esophagus that invade the upper trachea, and stomal recurrence after laryngectomy. Benign strictures in a cervical stoma or intact trachea resulting from tracheo-tracheal anastomosis, high-dose radiation therapy, or chronic inflammation are also indications. Additionally, an infected or bleeding tracheostoma, postoperative tracheal anastomosis necrosis, or large tracheo-digestive fistula may necessitate MT. Depending on the underlying cause, complete exenteration of the larynx, hypopharynx, or esophagus with esophageal substitution may be necessary in addition to creating the MT. The first case of this procedure was reported 85 years ago (1). However, the initial series of cases revealed catastrophic postoperative mortality rates of up to 50%, primarily due to massive hemorrhage from erosion of the neighboring brachiocephalic artery (2,3). Today, MT is still considered a demanding and challenging high-risk operation that is rarely performed. Achieving good outcomes requires meticulous attention to detail, a high level of surgical skill, and dedicated postoperative care. This systematic review aims to compile knowledge regarding operative techniques, outcomes specific to techniques and underlying diseases and quality of life. We present this article in accordance with the PRISMA reporting checklist (available at https://med.amegroups.com/article/view/10.21037/med-2026-0022/rc). Methods A systematic review was performed in January 2026. Eligible studies were identified through a systematic search of the PubMed database for case reports and case series addressing MT, including surgical techniques, indications, and quality-of-life outcomes. The search strategy was as follows: (“mediastinal tracheostomy”[tiab] OR “mediastinal tracheostoma”[tiab] OR “mediastinal tracheotomy”[tiab]) Reference lists of relevant original articles and review articles were screened manually to identify additional eligible studies. Publications were included irrespective of patient age, year of publication, or language. Articles published in languages other than English were translated using DeepL (DeepL GmbH, Cologne, Germany) before assessment. To prevent selection bias, literature screening and study selection were performed independently by both A.M.P. and J.P.E. Any discrepancies were resolved by discussion and consensus. The included studies were categorized according to the variables summarized in Tables S1-S3. Data are presented as medians and percentages for the overall cohort or for the respective subgroups, where applicable. Results The systematic review conducted in PubMed yielded 83 publications from 1951 to 2026. After screening titles and abstracts, 70 articles were selected for further examination, including their reference lists. Twelve studies were excluded because they did not meet the criteria. Among these, 6 were identified as duplicates due to repetitive publication: [Orringer & Sloan 1979 (4) removed, in Orringer 1992 (5); Wurtz 1988 (6) and Wurtz 2008 (7) removed, in Conti 2010 (8); Kato 1983 (9) removed, in Kato 1994 (10); Terz 1980 (11) removed, in Neifeld 1984 (12); Fujita 1990 (13) removed, in Fujita 1991 (14)]. Grillo & Suen 1992 (15) was not removed, even though believed to be part of Grillo & Mathisen 1990 (16). Additionally, Kubo 2018 (17) and Yamasaki 2020 (18) may contain some repetition but were retained. Six publications only had the English abstract of none-accessible Japanese or French articles, and these abstracts were included in the review because they contained information deemed relevant. Twelve additional records were identified through reference lists. Of the final 70 publications, 429 cases of permanent AMT, 6 cases of fenestrated AMT, 1 posterior MT, and 1 lateral MT arose. No conflicts or disagreements resulted between the two authors who independently reviewed the database. The literature selection process is displayed in the PRISMA flow diagram (Figure 1). Tables S1-S3 (1-3,5,8,10,12,14-77) summarize the collected cases. PRISMA flow diagram. MT, mediastinal tracheostomy. Discussion Operation techniques Of the 437 cases identified in this review, three types of MT were observed: dorsal MT (1/437, 0.2%), lateral MT (1/437, 0.2%), and AMT (435/437, 99.5%). These can all potentially be performed in a continuous trachea with a window as a fenestrated tracheostomy or, as seen in most cases, as a terminal, permanent tracheostomy. Dorsal MT This location has only been reported once, in 1951 (Table S1) (19). On the right side of the back, a 6 cm × 8 cm paravertebral window is made medial to the scapula. Segments of the third, fourth, and fifth ribs are then removed. The trachea is exposed, and a longitudinal incision is made in its posterior membranous wall to form a fenestrated stoma. Then, it is intubated with a large cannula, and secondary granulation of the transthoracic channel is anticipated. This procedure is historical because the dorsal opening is inconvenient for the patient’s treatment and self-care. Lateral MT This type has also only been described in one case so far (Table S2) (24). It was performed because severe kyphosis prevented true anterior placement of the tracheostomy. The procedure requires resection of the manubrium and left clavicle. Then, the trachea is transected and brought to the left lateral side. A muscle flap is required to cover the structures and enlarge the tracheal entry. This procedure should be considered a variation of the ATM, which is described in detail below. Permanent AMT With 429 reported cases (Table S3), permanent AMT is the most common type of MT. However, it has several sub-forms, each with details that vary and are significant to the outcome. Anterior chest wall access and removal Six of the earliest reports in the 1940ies and 1950ies describe bringing the trachea to the anterior thoracic wall by resecting a notch in the cranial manubrium of the sternum (n=1) (1) or by creating a medial hole in the manubrium remaining after sternotomy (n=5) (2,25). However, this method left a large distance between the residual trachea and the thoracic wall, as well as a large intrathoracic dead space. The skin covering this distance was susceptible to necrosis from the sharp edges of the manubrium and tension. Furthermore, the intrathoracic dead space created an environment conducive to infection and abscess formation. Therefore, this type of AMT was quickly abandoned. Access with resection of the entire manubrium was soon favored (20) and further developed into removal of the anterior upper thoracic “breastplate” (21). This approach was used in at least 96.0% (412/429) of reported cases. For “breastplate” resection, the manubrium and both clavicular heads are resected (3). Or in a more radical variant, all the medial part of the clavicles and portions of the adjacent first and second costal cartilages are removed (Figure 2A-2C) (21). Surgical approach to anterior mediastinal tracheostomy. (A) Anterior view and (C) Lateral view of “breastplate” (manubrium, clavicular heads and cartilages of first and second rib), marked in yellow. (B) Anterior view of exposed trachea and large vessels. (D) Lateral view of established anterior mediastinal tracheostomy. This “breastplate” removal unroofs the superior mediastinum, providing exposure to the intrathoracic trachea and large vessels (Figure 2B). It also exposes the thymus gland, pleura, and cervicothoracic esophagus. Furthermore, it eliminates dead space; the overlying skin usually falls into the anterior mediastinum and meets the trachea without tension. Additionally, the mobilized pectoralis major muscle falls back over the sharp edges of the bony chest defect. Five reported cases of very distal tracheal divisions involved a sternal division even below the sternomanubrial junction (47). In contrast, if a very distal division of the trachea is not required and additional skin mobility is not needed, a resection sparing the lower part of the manubrium and second costal cartilage is possible (12). However, none of the collected reports addressed this issue. Twelve cases (38,44,49,53,77) involved minimal resection of the chest wall by removing only the right half of the “breastplate” or performing a trapezoidal resection of the manubrium. This technique was first described in the 1970ies (26) and is gaining popularity in more recent days. It results in a more stable shoulder joint and better cosmetic outcomes, but requires a myocutaneous flap to adequately cover the sharp bony edges and dead space. Trachea preparation After the affected proximal part of the trachea is resected, distal tracheal mobilization is performed. This must be done carefully anteriorly and laterally to minimize the risk of devascularization of the latero-posterior blood supply. The trachea receives its blood supply primarily from branches of the inferior thyroid artery, the subclavian artery, and the bronchial arteries. These arteries are linked by lateral longitudinal anastomoses in the connective tissue adherent to the tracheal wall. If the esophagus needs to be removed, attention should be given to preserving the bronchial arteries as much as possible (39). Length of tracheal stump The optimal remaining length of the trachea for a regular AMT is considered to be ≥5 cm (43). By 5 cm or more, transposing or dividing neighboring structures is usually unnecessary. Thirty of the 67 publications, including 192/429 cases, did not state the length of the tracheal stump. Among the reported cases, most were around the recommended 5cm. However, several were significantly shorter. Eight patients had a remaining stump of ≤4 cm, and an additional 25 patients with vague case reports could be expected to be in this group also, bringing the total to more than 30 cases. A stump of ≤3 cm was described in 15 patients (10,18,21,30,33,41,44,48,51-53,63,69,70), likely missing additional cases. Six cases had a stoma of ≤2 cm (12,40,41,52,65,66), and an even shorter stump of 1cm was established in two cases (12,64). Furthermore, one case (40) of a 0 cm remaining trachea, meaning a direct entry at the carina bifurcation, was successfully performed. Since the remaining trachea bends anteriorly to form the tracheostoma, it is best to have a longer posterior edge that extends anteriorly. Therefore, whenever possible, the trachea should be divided obliquely (Figure 2D), leaving the posterior membranous part longer than the anterior cartilaginous part. If only one side of the trachea is affected by tumor, a longer section of healthy trachea should be preserved. A longer section of trachea, even on one side, provides a broader suturing area to the anterior chest wall. This can prevent the residual trachea from dropping into the posterior mediastinum (62). During construction of the mediastinal stoma, cannulating the distal trachea with a curved tracheostomy tube ensures proper cross-field ventilation (78). If the tracheal stump is very short, the orifice of the left main bronchus can be intubated with a non-kinking endotracheal tube (52), or a Y-type stent (64) placed in the left and right main bronchi to enlarge the trachea. Local vascular division The distal trachea is in close proximity to the brachiocephalic artery and left brachiocephalic vein (Figure 3A). During distal tracheal preparation, the left brachiocephalic vein may be ligated and divided to improve exposure of a short tracheal stump due to tumor involvement or prophylactically to prevent rare fatal erosion later on (Figure 3B) (54). This vein was ligated and divided in 35 cases and an estimated 25 more cases that were not specified in the case series. This would result in a 14% ligation rate (60/429). However, most publications did not specifically address this issue. Based on a few well-documented, larger case series (3,8,10,54), we estimate that brachiocephalic vein division is performed much more routinely, at rates of 100% (6/6), 18.8% (3/16), 15.4% (2/13), and 2.6% (1/38), respectively. In one case, the brachiocephalic vein was divided and reconstructed with a major saphenous vein to improve exposure (35). Tracheal transposition techniques and vascular relationships in anterior mediastinal tracheostomy. (A) Regular situated anterior mediastinal tracheostoma behind great vessels. (B) Exposed trachea by division of left brachiocephalic vein. (C) Exposed trachea by division of brachiocephalic artery. (D) Transposition below brachiocephalic artery. (E) Transposition between ascending aorta and superior vena cava. (F) Transposition to the outmost right behind superior vena cava. The trachea must also be dissected away from the brachiocephalic artery. This procedure should be performed bluntly to avoid skeletonizing the surrounding adventitia and minimize the risk of tension and subsequent erosion. In at least 14 cases (3.3%; 14/429), the brachiocephalic artery was electively and permanently divided proximal to the carotid-subclavian bifurcation to prevent erosion later on or to improve exposure of the trachea (Figure 3C). In the 1970ies and 1980ies elective division was popularized (4,16) for anatomy with regular aortic branches, but it appears obsolete in more recent times. There is a risk of ischemic stroke, as observed in 1 of 6 cases in a case series, even when previous angiography and intraoperative electroencephalography were regular (15). Nowadays, if exposure or tumor necessitates division of the artery, it is rerouted with a graft, as described in 5 cases (18,51,75). Alternatively, proximity to the trachea is often resolved by relocating the tracheal stump and providing flap coverage, as described in the following sections. Tracheal transposition/relocation Typically, a standard mediastinal stoma is placed cranial to the brachiocephalic artery and left brachiocephalic vein (Figure 3A). However, if there is any concern about tension or close contact between these structures, a transposition maneuver is recommended. This transposition permits an additional elevation of 1.5 to 2 cm of the end of the trachea out of the mediastinum, which is valuable for a short stoma. Additionally, prophylactic division of the brachiocephalic artery and brachiocephalic vein can be avoided. Of the collected cases, more than half were declared to have a translocated trachea (227/429). This technique was first described in 1959 (2). A space is developed beneath and to the right of the brachiocephalic artery. Then, the trachea is repositioned below the brachiocephalic artery and above the right brachiocephalic vein (Figure 3D) (10,38,40,47). If greater mobility is needed, the trachea can be translocated between the superior vena cava and the proximal brachiocephalic artery on the aortic arch (Figure 3E) (10,47,48,66,70). In some cases, a complete transposition of the trachea to the right side of the superior vena cava is performed (Figure 3F) (5). Despite the large number of transpositions, the location was rarely reported specifically. Stomal coverage Appropriate stomal coverage is important for eliminating potential dead spaces, protecting vessels, and keeping the stoma vitalized (Figure 4A). At the same time, tension must be minimized. The tracheal stump should not be brought out of the thorax, but the skin must meet deeply. Careful approximation of the tracheal mucosa and the cervical skin is important. Direct collar skin coverage In at least 87 cases (20.3%), and probably many more, the tracheostomy was incorporated directly into the elongated cervical incision as the wound was closed (Figure 4B) or several centimeters below the incision by excising a 1.5 to 2 cm button of skin. This technique (4), requires elevating the skin overlying the upper sternum, medial clavicles, and first and second costal cartilages by vigorously retracting the skin downward and temporarily flexing the neck. This technique avoids another incision but leaves questionable vascularized skin and tension. Therefore, it is rarely applied in more recent years. Defect coverage techniques. (A) Wound defect after “breastplate” removal. (B) Direct collar skin coverage. (C) Bipedicled upper thoracic apron flap and (D) thoracoacromial nipple flap; the caudal defect is reconstructed with a split-thickness skin graft in each variant. (E) Preparation and (F) reconstruction by pectoralis major myocutaneous flap. Bipedicled upper thoracic apron flap = “visor” flap This was applied in at least 59 cases (13.8%). Unlike direct skin coverage, it is tensionless. For this technique (Figure 4C), a transverse cervical incision is made, as well as a second transverse incision in the submammary line (4th intercostal space) from the anterior axillary line to the opposite anterior axillary line. A large flap is then elevated between these two incisions from the pectoral fascia, sparing the lateral feeding blood vessels. This gives the flap its name, “bipedicled”. The mobilized skin is moved cranially into the sternal defect and anastomosed to the trachea. The lower incision defect requires coverage with a split-thickness skin graft, usually taken from the thigh. This technique was propagated in the 1960ies (21) but appears to have been widely abandoned in recent times. Thoracoacromial nipple flap This is the hemi version of the bipedicled upper thoracic apron flap and has also been used since the 1960s for various head and neck surgeries (79,80). Thirteen cases were reported to have been performed this way, but probably several more in this review were not properly reported. This flap (Figure 4D) is created by mobilizing the skin from the underlying pectoralis muscle after making a submammarian, transverse cervical, and medial incision. Then, the flap is rotated superiorly and medially. This technique can resurface a more cranial mediastinal and cervical defect. The inferior defect created by mobilizing this flap is reconstructed with a split-thickness skin graft. Pectoralis major myocutaneous flap With at least 141 cases (32.9%), this is the most widely used coverage technique found for AMT. It is frequently used in more recent reports. The variant with a myocutaneous island is especially popular, appearing in 32 cases. The use of an even larger deltopectoral flap brought into the mediastinal defect is also described in 23 cases (17,74). The pectoralis major myocutaneous flap was first used in the early 1980ies, adapted from head and neck reconstruction (81,82). This flap provides well-vascularized, bulky muscle that fills the dead space in the upper mediastinum, creating an interposition between the trachea and the brachiocephalic artery. Harvesting of the pectoralis major myocutaneous flap requires division of muscle fibers running towards the humerus insertion, and elevation of the entire muscle which is separated from the chest wall and pedicled on its acromiothoracic vascular blood supply (22). A cervical and oblique median skin incision is required for dissection and an oval skin paddle on top of the flap is left in place, outlined on its vascular axis (Figure 4E). The mobilized pectoralis major muscle flap with the oval skin paddle is then rotated into its new position (Figure 4F). The trachea is passed through a fenestration in the muscle and sutured to the border of the skin paddle (78), or, alternatively, it is passed through a fenestration in both the muscle and the skin paddle (39). In other variants, the pectoralis muscle flap is split, with one portion inserted between the trachea and brachiocephalic artery and the other portion used to tube the trachea (39). The trachea is usually sutured to the skin and skin paddle (41), but if it is too short, it can be sutured to the inferior muscle level to create an extension of the trachea by the muscle (53). The right pectoralis muscle is predominantly used for coverage. Indeed, in the case of a left-sided flap, and if ligation of the left brachiocephalic vein is required, this can lead to venous congestion and fatal flap necrosis, as reported in one case (54). Other muscle flaps There are reports of successful use of other muscle flaps: six cases of a right-sided latissimus dorsi musculocutaneous flap (14,38,61) were tunneled through the anterior mediastinum by separating the major and minor pectoral muscles. Two cases involved a cervical musculocutaneous flap consisting of the sternocleidomastoid muscle (47,70). One case involved a pedicled myocutaneous rectus abdominis muscle flap (50). Six more recent cases (56,64,71,72) involved a free chimeric anterolateral thigh flap consisting of the musculus tensor fasciae latae and the vastus lateralis, as well as a large skin section (20 cm × 10 cm). This flap provides skin for tracheostomy and neck coverage, sometimes even for reconstruction of esophageal defects, as well as a muscle bulk to separate the brachiocephalic artery from the relocated trachea. However, it requires microsurgical vascular reanastomosis. Omental flap This was used in 38 cases. The omentum has good vascularity, the ability to induce neovascularization, and is resistant to infection. The omental pedicle is prepared by separating the omentum majus from the colon and stomach while leaving the right gastroepiploic artery intact to serve as its blood supply. Then, the flap is brought up retrosternally and placed in the mediastinal defect to cover the space between the vessels and the trachea. This technique is especially suitable if gastric reconstruction or colonic interposition is performed simultaneously (4,5,16,48). The mesentery was also used in 12 cases in which a neo-esophagus was created simultaneously (18). Thymus flap Two cases of AMT involved the use of the thymus for coverage (63,65). Thyroid lobe Two cases also used a thyroid lobe for this purpose (30,62). Fenestrated AMT A total of 6 cases were identified in which a fenestrated AMT was performed by canulating the intact trachea through a ventral hole into the tracheal wall (Table S1) (20-23). Five cases served for palliative purposes where proximal tracheal tumor obstruction occurred. One case was performed for ventilatory assistance at home in a patient with severe kyphoscoliosis (22). In 2 cases (20,21), the manubrium was removed. In 4 more cases (23), a notch was made in the cranial manubrium after a cervical skin incision. With this technique, the neighboring vessels are not protected and remain at risk. Postoperative treatment Postoperatively, MT patients require close monitoring of their airways and hemodynamics. They are usually observed in an intensive care unit (83). Postoperative mechanical ventilation is seldom required after an isolated MT procedure (54). However, with a larger extent of operation, such as concomitant laryngopharyngoesophagectomy, mechanical ventilation is continued for 12 to 72 hours (33,48,58,61). Maintaining the position of the endotracheal tube above the carina is critical and can be challenging when only a short length of trachea remains. This can be accomplished with a wire-reinforced endotracheal tube placed through the tracheal stoma or a customized, shortened tracheostomy tube (83). Trauma to the trachea must be minimized by using the lowest possible pressure in the endotracheal tube balloon. After extubation, the stoma is cannulated and humidified constantly via nebulization. Until the tracheostoma heals, the low-pressure cuff cannula is changed using a silicone tube and a guide. In some cases (58), the stoma is decannulated only after it has healed completely to avoid tracheal stenosis in the mid- to long term. In contrast, a large case series (54) found that the tracheostomy tube was unnecessary if extubation was successful; patients could even be nursed in a general ward. Frequent sputum suctioning is advised to prevent crust drying, especially around the tracheostomy, as this can cause blockage and asphyxiation. To prevent gastric contents from regurgitating into the tracheostoma, a nasogastric tube should be inserted. Regurgitation commonly occurs during endotracheal tube suctioning and coughing. This is particularly true after esophagectomy and reconstruction, when both esophageal sphincters are affected. Therefore, nasogastric tube decompression should continue until the patient can sit up and cough independently. Furthermore, if the thyroid or parathyroid glands were affected during surgery, postoperative hypoparathyroidism should be monitored within hours, and hypothyroidism monitored during the first days and weeks following surgery. Outcomes General surgical outcomes Postoperative mortality This review revealed an early postoperative mortality rate of 7.0% (30/429) after permanent AMT. A decreasing trend was found between the earliest and most recent eras: 1941–1980, 1981–2000, and 2001–2026. The respective mortality rates were 17.6% (9/51), 6.9% (5/72), and 5.2% (16/306). Impact of procedure It is difficult to determine how much of the mortality rate is attributable to AMT grafting. Our review shows that permanent AMT was often performed on older patients with multiple comorbidities. Several patients required not only a tracheal resection and permanent AMT construction that takes around 4 hours (52,73), but complex cervicothoracic exenterations such as laryngopharyngoesophagectomy requiring 11 hours (8,16,18,52,65,67,74,75) to 18 hours (18,74) and an average blood loss of 1,200 mL (18,67,75). At least 31.0% (133/429) underwent total esophagectomy with reconstruction, and most of these patients also underwent pharyngolaryngectomy with total esophagectomy. This procedure is considered high risk and often results in anastomotic leak or graft ischemia. The current morbidity and mortality rates are 66.9% and 4.6%, respectively (84). A pharyngocutaneous salivary fistula is also a common postoperative complication after total laryngectomy, with an incidence rate of 21.7%, triggering infection (85). Furthermore, neck dissection is a risk factor for devascularization, which can lead to necrosis. Additionally, local radiation therapy may impact outcomes; however, no clear correlation with major complications after AMT was found in one study (18). Technique specific outcomes Vascular rupture The most feared complication of AMT is rupture of a major blood vessel at the stoma site. This occurs as a result of pressure necrosis caused by skin tension, cannula erosion, or necrosis triggered by inflammation. Of the studied population, a total of 29 great vessel ruptures were reported, accounting for 6.8% (29/429) of permanent AMT. Of these ruptures, 21 were specifically stated as brachiocephalic artery ruptures. Five cases affected the brachiocephalic vein (5,14,54,74). Such abrupt bleeding usually fills the airways and causes immediate asphyxiation. The outcome was fatal in 89.7% (26/29) of cases. Brachiocephalic artery rupture mostly occurred within the first few weeks after surgery, ranging from 7 days to 5.5 months. Brachiocephalic vein rupture occurred as late as 7 months after surgery. There was a decreasing trend in bleeding occurrence between the eras of 1941–1980, 1981–2000, and 2001–2026: 15.7% (8/51), 6.9% (5/72), and 5.2% (16/306), respectively. This suggests an improvement in surgical technique. One ruptured brachiocephalic vein was successfully ligated (14). One case of brachiocephalic artery and aortic bleeding was successfully managed by dividing the ascending aorta and inserting a vascular prosthesis from the ascending to the abdominal aorta (40). An additional case of brachiocephalic artery bleeding was successfully ligated using a femoral bypass graft (42). A third case of brachiocephalic artery rupture was initially managed successfully with graft replacement but ruptured fatally 25 days later (17). In such emergency situations, cardiopulmonary bypass can ensure adequate oxygenation and hemodynamics (86). Flap type on vessel rupture Five vessel ruptures stated using skin flaps, and at least 7 more were likely to have had a skin flap, giving this type of coverage a risk of 5.6% (5/89) to 13.5% (12/89). Nine ruptures occurred using a pectoralis muscle flap, giving a risk of 6.4% (9/141). Two ruptures occurred using bipedicled thoracic apron flaps, meaning a 3.4% risk (2/59). And one rupture occurred using an omentum flap, meaning a 2.6% risk (1/38). Five additional cases of vascular rupture did not state the type of stomal construction. Length of tracheal stump on vessel rupture A shorter tracheal stump requires more demanding surgery for permanent AMT. Within the first few months after surgery, a stump of ≤3 cm had a failure rate of 6.7% to 26.7% (1/15 to 4/15), as 3 cases (10,18,41) could not be clearly identified (10,18,21,30,33,41,44,48,51-53,63,69,70). For stumps measuring ≤2 cm, the failure rate was 16.7% to 33.3% (1/6 to 2/6), as one case (41) could not be identified (12,40,41,52,65,66). A 1 cm stump was unsuccessful in both reported cases (12,64). In contrast, one 0cm case was successful (40). Based on this encouraging result, a short stump may not be considered a contraindication to surgery per se. Transposition of stump on vessel rupture Of the major vessel ruptures, 27.6% (8/29) occurred with the trachea transposed (2,8,12,29,40,42). Of the remaining 72.4% (21/29) of ruptures, only 3 were clearly reported to have occurred with the trachea in its regular position (3,25). However, it can be considered that most of the others were also in the regular position because otherwise it would have been stated. Assuming this, transposition may have a protective effect on vessel rupture. Tracheal necrosis This was reported in 36 cases, accounting for 8.4% (36/429) of the reviewed permanent AMT population. However, this appears to be an underestimation, as even recent large case series describe it as occurring at rates ranging from 2.9% (1/34) (17), 11.1% (3/27) (18), 28.9% (11/38) (54), and up to 33.3% (4/12) (61). It was declared the underlying reason for death in 3 cases (47,61,64) as the risk of consecutive mediastinitis and sepsis is high. Three cases (40,58,64) were described as undergoing reoperation with necrosectomy of the affected cartilage rings and reimplantation with vital muscle wrap, while 15 cases (54,61) were treated conservatively. The rest did not state the treatment. Necrosis results from tension on skin suture lines, inadequate flap wrap, as well as overly radical mobilization and devascularization of the tracheal stump, especially when radical cervicothoracic lymph node dissection and esophagectomy are necessary. To evaluate the appropriate blood supply to the tracheal tip, it was suggested to judge this based on gross findings of bleeding. Therefore, the trachea is resected until sufficient bleeding from the excised piece is confirmed (74). Tracheal stenosis This is a long-term problem that occurs after partial tracheal necrosis due to insufficient vascularization from surgery or prior radiation therapy, or due to local inflammatory processes such as a neo-esophagus anastomosis leak or an epipharyngeal leak. Of the entire collected permanent AMT population, 9.6% (41/429) of cases reported on this issue. However, several cases lacked further observation. In larger case series, the reported rates of long-term tracheal stenosis were 14.3% (1/7) (48), 16.7% (2/12) (61), 35.7% (5/14) (16), and 47.4% (18/38) (54). However, the last series found that using a pectoralis muscle flap reduced the stenosis rate to 7.1% (54). Another case series performed an additional V-shaped incision in the tracheal membrane to avoid stenosis (39). Tracheal stenosis was treated by dilatation in 3 cases (57,61) and by operative revision in 5 cases (16), while the rest of the reports did not specify the treatment method. Wound infection Only 33 cases of wound infection or mediastinitis were reported. Several publications did not address this topic, suggesting a high percentage of missing cases. Therefore, no conclusions can be drawn. Muscle/skin flap dehiscence/necrosis Only 5 cases reported flap dehiscence, and 12 cases reported flap necrosis. This is a significant issue, as several wound infections and fatal complications occur alongside it. These scarce data do not allow for conclusions on flap types. Flaps should be carefully monitored, and dehiscence should be treated with vacuum-assisted therapy (61). Lung herniation This was reported in two cases (50,57) resulting from a large chest wall resection. They were both treated conservatively. Pneumonia At least 33 cases of postoperative pneumonia were reported. This is likely a strong underestimation of the true incidence. MT patients appear to be more susceptible to these types of infections because their shorter tracheas may reduce auto-positive end-expiratory pressure, which may be associated with an increased incidence of pulmonary complications (74). Notably, in two cases (5,58), pneumonia was the direct cause of death. Underlying disease specific outcomes Conti et al. 2010 (8) attempted to review their case series alongside 5 other previous case series in order to compare permanent AMT patients with different types of carcinoma. They concluded that esophageal carcinoma had a poor 3-year survival of 11%. In contrast, in the subgroup of patients with head and neck malignancy, the 3- and 5-year survival rates were 57% and 43%, respectively. Bagheri et al. 2013 (58) found a survival rate of 1.1 years for stomal recurrence of laryngeal cancer, 2.3 years for esophageal cancer, and 2.4 years for primary tracheal malignancy in their case series. Yamasaki et al. 2020 (18) reported a 3- and 5-year overall survival rate of 38.6% and 25.7%, respectively, for esophageal cancer patients in their case series. Due to the scarcity of MT cases, the large heterogeneity of MT patients, changing therapy approaches over time, as well as the often poorly reported history and staging status of malignancy, we abandoned a comparison within the 437 relieved cases. Until there is strong evidence for MT-specific cancer indications, profound interdisciplinary decisions should be made on an individual basis. Quality of life outcomes So far, no study on quality of life has been published, and only a few publications have offered insight into the topic. At first glance, MT appears to be a mutilating palliative intervention. However, this review revealed that some permanent AMT patients lived with the stoma for more than 10 years (5,8,45). Moreover, they were able to resume their daily lives at a nearly normal level (62), with good airway patency (41) and become highly independent. Examples include “returned to work as a plumber” (2), “playing golf” (3), and “healthy after 13 years with an excellent gastric voice and working as a high school teacher” (45). Recovering from surgery and adapting to a new stoma certainly requires time and sometimes includes rehabilitation and support. Additionally, the underlying disease and subsequent treatments may compromise quality of life. As a cervical stoma, an MT requires regular care, including humidification, cleaning, and suctioning to prevent crusting and infection. Cold air and dry or dusty environments are often poorly tolerated. Furthermore, voice impairment or loss may necessitate the use of compensation techniques. Berthet et al. (61) reported that, in their permanent AMT series, seven (58.3%) patients experienced long-term discomfort due to insufficient anterior chest wall rigidity after manubrium and clavicle head resection. Sisson and Goldman (29) also described moderate restriction of arm mobility and strength due to chest wall resection and pectoralis major flap. However, most of their patients compensated well with few complaints, even as they demanded strenuous physical labor. Long-term tracheal stenosis (5,16,54,61), which requires revision or dilatation, might impact quality of life. In permanent AMT cases with an additional esophagectomy, regurgitation problems and other intestinal issues may arise (5). Grillo and Mathisen (16) considers a probability of survival of less than 6 months to not warrant a permanent AMT operation cause of its magnitude, as a substantial amount of time would be spent recovering from the procedure. Yamasaki et al. (18). report in their case series that 93% (25/27) of patients were eventually able to live at home after 21 days to 3 months. Seven patients were temporarily transferred to a rehabilitation facility. A palliative AMT approach was also found to improve quality of life (23). This technique relieves respiratory deficiency and prolonged orotracheal intubation. In some cases, it provides greater independence and, in one case, allows for discharge home. Alternatives to MT In general, end-to-end anastomosis is not possible for tracheal resections exceeding 50% or 5–6 cm. Besides of the option of grafting an MT, current research on tracheal and partial laryngeal replacement strategies, as well as tracheal elongation to create a standard cervical stoma, remains widely experimental. Principally, a synthetic stent can be placed as a palliative option for maintaining lumen patency. However, this leads to fatal infection and vascular erosion over time. The same problems occur for tracheal replacement by a synthetic prosthesis (87,88), which led to the abandonment of this approach (89). To elongate the tracheal stump to construct a standard cervical stoma, a few small case series and single cases have used muscle flaps (90-93). However, at least 2 cases resulted in great vessel rupture (90,91). Therefore, the superiority of this technique over AMT has not been demonstrated. For entire reconstructions, skin, local muscle and forearm or tibial flaps have been used in tubularized fashion, reinforced by autogenous rib strips, resorbable mesh, or metal stents. However, beside of the complex procedure, ongoing tube maintenance as well as morbidity and mortality are increased (94-96). Cadaveric donor trachea transplantation has been reported in 8 cases (89). In a first step the donor trachea was wrapped in the recipient's forearm fascia or omentum for 2 to 4 months to promote heterotopic revascularization. In a second step, the conditioned trachea was transferred with microvascular anastomosis (97-99). Lifelong immunosuppression is required, which is a contraindication in case of cancer. To prevent immunosuppression, biological tracheal replacement strategies have been tested in small case series. These strategies used either a synthetic or cadaveric scaffold coated with cellular components and growth factors (100-103). However, scientific and ethical fraud led to the retraction of publications and the cessation of this project (89). In recent years, the most widely used method has been allografts of the aorta, with a total of 51 cases (89). Although they do not require immunosuppressive therapy, they do require initial intraluminal stenting for at least 1.5 years. Despite losses due to dehiscence, hemorrhage, and infection, some promising long-term outcomes are achieved (104-106). Conclusions This systematic review revealed that MT is a rarely performed and challenging procedure. Of these, permanent AMT is the most frequently performed type. To achieve the best possible outcome, the indications and disease-specific long-term values should be evaluated interdisciplinary. A short remaining tracheal stump poses surgical challenges and an increased postoperative risk, but it may not be an absolute contraindication. The most favorable and modern standard for MT appears to be: Extended hemi-manubrium resection only, to preserve better chest wall stability; Extended hemi-manubrium resection only, to preserve better chest wall stability; In cases of a short tracheal stump, transposition of the trachea to increase its length and avoid contact with the brachiocephalic artery; In cases of a short tracheal stump, transposition of the trachea to increase its length and avoid contact with the brachiocephalic artery; Coverage of the mediastinal dead space in the upper mediastinum with a myocutaneous flap to ensure sufficient vascularity and avoid dead space and tension in the skin suture line of the stoma. Coverage of the mediastinal dead space in the upper mediastinum with a myocutaneous flap to ensure sufficient vascularity and avoid dead space and tension in the skin suture line of the stoma. Quality of life appears high enough to manage daily living and, in some cases, strenuous work. Further studies are needed. Supplementary The article’s supplementary files as Available at https://med.amegroups.com/article/view/10.21037/med-2026-0022/prf